Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P0
Near historical low
vs 2Y Ago
-416x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-2608.07%
202497.56%
20236.27%
2022-23.67%
2021-46.26%
2020-35.89%
2019-75.00%
2018-12.39%
20170.00%